home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Software Vault: The Sapphire Collection
/
Software Vault (Sapphire Collection) (Digital Impact).ISO
/
cdr14
/
med9410l.zip
/
M94A1919.TXT
< prev
next >
Wrap
Text File
|
1994-10-24
|
3KB
|
41 lines
Document 1919
DOCN M94A1919
TI Development of algorithms for distribution and management of therapeutic
schemes for AIDS patients in Brazil--1993.
DT 9412
AU Del Bianco R; Ninomya T; Rodrigues L; Sereno A; Ministry of Health,
Brasilla, Brazil.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):421 (abstract no. PD0294). Unique
Identifier : AIDSLINE ICA10/94370656
AB OBJECTIVES: To discuss the use of specific follow-up instruments in the
evaluation and control of AIDS medication distribution. METHODS: In
1993, the National AIDS program distributed nationally (to all 27
States) recommendations for AIDS diagnosis and treatment. The manual
consists of standardized guidelines for adequate use of antiretroviral
drugs and specific schemes for treatment of opportunistic infections.
The guidebook also enables the States to determine and inform to the PNC
DST/AIDS the annual demand and available stocks of each medication.
RESULTS: We utilized the guidelines to manage therapeutic regimens and
distribution of highly expensive drugs as: AZT, ddl, Gancyclovir and
Pentamidine. The following problems were identified in the guidelines:
gaps in recommendation(individuals managed differently for no apparent
reason) and unnecessary complexity (opportunities to simplify the
guideline without altering recommendations). After the implementation of
the guidebook all states began to inform monthly the use, validity and
stock of each controlled drug. Medications distribution depended
basically on the feedback information. The AZT actual national cost in
1993 was U$ 6 million, 80% of the estimated initially. CONCLUSION: The
implementation of specific algorithms facilitates contact with the
States and permits continuous flow of drugs supplies. It allows the PNC
DST/AIDS to optimize the drug distribution with reduction of losses and
costs.
DE Acquired Immunodeficiency Syndrome/*DRUG THERAPY/ECONOMICS Algorithms
Antiviral Agents/ECONOMICS/*THERAPEUTIC USE Brazil Costs and Cost
Analysis *Follow-Up Studies Guidelines Health Services/*ORGANIZATION
& ADMIN Human Manuals Zidovudine/ECONOMICS/THERAPEUTIC USE MEETING
ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).